PATH-SS for Post-Traumatic Stress Disorder
(PATH-SS Trial)
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to test a brief, new psychotherapy (called Positive Processes and Transition to Health - Single Session, or PATH-SS) that aims to provide relief for people who are suffering after experiencing a sexual assault. This research will explore whether this new psychotherapy reduces sexual assault related distress, including posttraumatic stress and depression symptoms. The main questions it aims to answer are: Does PATH-SS leads to improvements in PTSD and depression symptoms (pre- to post- and 1-month follow-up)? Do participants perceive PATH-SS to be acceptable, helpful, and do they complete/adhere to treatment? Participants will complete a pre-treatment/baseline assessment to confirm eligibility, and those who are eligible will receive the single-session intervention and will complete a post-treatment and a 1-month follow-up assessment of stressor-related symptoms.
Research Team
Norah C Feeny, PhD
Principal Investigator
Case Western Reserve University
Eligibility Criteria
This trial is for individuals who have experienced a sexual assault and are dealing with related distress, including symptoms of PTSD and depression. To participate, they must complete an initial assessment to confirm eligibility.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- PATH-SS (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Case Western Reserve University
Lead Sponsor
Eric W. Kaler
Case Western Reserve University
Chief Executive Officer since 2021
PhD in Chemical Engineering from the University of Minnesota
Stanton L. Gerson
Case Western Reserve University
Chief Medical Officer since 2020
MD from Harvard Medical School